Introduction
============

Gastrointestinal leaks are abnormal communications between the intraluminal and extraluminal compartments as a result of a defect in the integrity of the gastrointestinal wall [@JR1611-1] . They usually occur due to defects at surgical suture sites, being associated with a high risk of mortality and morbidity. Leaks are responsible for the majority of surgical mortality [@JR1611-2] [@JR1611-3] [@JR1611-4] . In addition, delayed closure of leaks may result in chronic fistulae formation, which are difficult to manage endoscopically.

Prevalence of upper gastrointestinal (UGI) anastomotic leaks has increased in recent years. Leaks related to oncologic surgery leaks have been reported in 8 % to 26 % after distal esophagectomy and in 3 % to 12 % after total gastrectomy [@JR1611-3] [@JR1611-5] ; bariatric surgery leaks have been reported in 2 % to 5 % of patients after Roux-en-Y gastric bypass (RYGB) and in 1 % to 2 % after sleeve gastrectomy [@JR1611-6] [@JR1611-7] .

Treatment of UGI anastomotic leaks remains controversial, as indications for surgical, conservative and endoscopic therapy remain non-standardized. Traditionally, surgical therapy has been the mainstay of treatment for anastomotic leaks; however, it tends to be complex and is plagued by high rates of morbidity [@JR1611-8] . Over the last decade, interventional endoscopy has evolved as an effective and less invasive alternative to primary surgery, changing the management paradigm for UGI leaks. A variety of techniques are currently available to reestablish the continuity of the digestive tract, prevent or treat infection related to the leak, prevent further contamination, drain potential collections, and provide nutritional support [@JR1611-9] . Endoscopic options include stent placement (metallic, plastic and biodegradable), endoscopic vacuum therapy (EVT), endoscopic internal drainage (EID), through-the-scope \[TTS\] and over-the-scope clips \[OTSC\], endoscopic suturing, endoscopic septotomy plus balloon dilation and tissue sealants [@JR1611-9] . Theoretically, all of these can be used alone or with a multimodality approach, with the approach chosen being tailored to the clinical and morphologic presentation but also largely institutional dependent and based upon availability of devices and accessories.

Even though endoscopic therapy may be associated with an improved outcome and better quality of life, there is no definite consensus on the most appropriate therapeutic approach in management of UGI anastomotic leaks. The current study was designed to explore the current practices in the management of UGI anastomotic leaks of a panel comprising international expert therapeutic endoscopists with experience in leaks to help design and inform future prospective studies.

Methods
=======

An online survey was developed to assess the opinion and practice of a panel of international expert therapeutic endoscopists regarding management of UGI anastomotic leaks. The participants were selected based on publications published on PubMed between January 2013 and April 2018 regarding endoscopic treatment of UGI anastomotic leaks. A total of 226 publications were found, corresponding to 182 different authors with available emails (first, last or corresponding authors). The survey was initially distributed, tested and optimized among 12 selected therapeutic endoscopists (ERP, AR, GD, GM, JD, JEvH, JMC, MGN, MS, PE, VK and MAK). Nineteen of the 182 obtained e-mail addresses were inactive. In August 2018, 163 participants were invited via an e-mail link to an online survey programme ( <http://www.surveymonkey.com> ), followed by a total of 3-weekly reminders.

The survey consisted of 35 opinion-probing questions ( **Appendix 1** ) and 4 short clinical cases ( [Fig. 1](#FI1611-1){ref-type="fig"} ). With regard to the clinical vignettes, participants were asked to choose one option between the different endoscopic therapies available.

![Clinical case 1: 52-year-old man with subcutaneous emphysema and respiratory insufficiency after Ivor-Lewis esophagectomy due to esophagus squamous-cell carcinoma; chest CT with oral contrast revealed a 12-cm intrathoracic collection with communication with the gastric tube; upper endoscopy revealed a severe anastomotic leakage 29 cm from the incisors. **b** Clinical case 2: 42-year-old woman, body mass index 38 kg/m ^2^ , who underwent laparoscopic sleeve gastrectomy, without drain placement; 10 days later, she presented with a left pneumonia; chest CT with oral contrast revealed a 4-cm intrathoracic collection with communication with the gastric tube; upper endoscopy revealed a 20-mm anastomotic leakage 35 cm from the incisors; no stricture was present at the level of the incisura angularis. **c** Clinical case 3: 38-year-old man, with a body mass index of 40 kg/m ^2^ , who underwent a Roux-en-Y gastric bypass, and presented 6 days later with fever and leukocytosis; CT with oral contrast revealed an 8 cm intraabdominal collection with communication with the gastric pouch; upper endoscopy revealed an anastomotic leakage 44 cm from the incisors; **d** Clinical case 4: 72-year-old man with recurrent leukocytosis and fever after total gastrectomy ; CT with oral contrast revealed contrast extravasation between the gastrointestinal lumen and the intra-abdominal cavity; upper endoscopy revealed a severe anastomotic leakage 41 cm from the incisors.](10-1055-a-1005-6632-i1611ei1){#FI1611-1}

The final percentage in multiple-choice questions may exceed 100 %, as several respondents have chosen more than one answer. Average ranking (AR) in [Table 1](#TB1611-1){ref-type="table"} and **Supplementary Table 1** was calculated to determine which therapeutic choice was most preferred overall. It was calculated as follows, where "w = weight of ranked position" and "x = response count for answer choice"; weights are applied in reverse:

![](10-1055-a-1005-6632-i1611ei5){#FI1611-5}

###### Techniques rating from the most frequently used to the less frequently used.

                                               First most used   Second most used   Third most used   Fourth most used   Fifth most used   Sixth most used   Seventh most used   Total   Average ranking
  -------------------------------------------- ----------------- ------------------ ----------------- ------------------ ----------------- ----------------- ------------------- ------- -----------------
  Stent placement                              52.1 %            32.4 %              8.5 %             4.2 %             --                 1.4 %            --                  70      6.3
  Endoscopic vacuum therapy                    15.5 %            14.1 %              7 %               7 %                8.5 %            15.5 %            11.3 %              56      4.1
  Endoscopic suturing                           1.4 %             8.5 %              9.9 %            14.1 %             11.3 %            15.5 %            11.3 %              51      3.4
  Tissue sealants                               7 %               5.6 %             11.3 %            14.1 %             15.5 %            21.1 %            12.7 %              62      3.4
  Over-the-scope clips                          4.2 %            16.9 %             33.8 %            21.1 %              9.9 %             2.8 %             2.8 %              65      4.6
  Endoscopic septotomy plus balloon dilation    2.8 %            11.3 %              4.2 %             8.5 %             15.5 %             8.5 %            16.9 %              48      3.3
  Endoscopic internal drainage                 16.9 %             9.9 %             21.1 %            16.9 %             14.1 %            --                 2.8 %              60      4.7
  Not applicable                               --                 1.4 %              4.2 %            14.1 %             25.4 %            35.2 %            42.3 %                      

Ideal patient characteristics for each endoscopic technique were based on the majority of respondents' answers ( [Table 2](#TB1611-2){ref-type="table"} ).

###### Ideal patient characteristics for each endoscopic technique.

                          Ideal patient characteristics [1](#FN1611-1){ref-type="table-fn"}                                               
  ----------------------- ------------------------------------------------------------------- -------- -------- --------------- --------- --------
  Time of leak                                                                                                                            
  Acute                   93.8 %                                                              96.8 %   48.7 %   89.5 %            3.2 %   54.3 %
  Chronic                 17.2 %                                                              19 %     71.8 %   31.6 %          100 %     65.2 %
  NO/NI                   n = 7                                                               n = 8    n = 32   n = 33          n = 40    n = 25
  Leak size                                                                                                                               
  0 -- 1 cm               54.1 %                                                              77 %     25 %     64.7 %           51.9 %   63.6 %
  1 -- 2 cm               63.9 %                                                              47.5 %   40 %     50 %             63 %     65.9 %
  2 -- 3 cm               55.7 %                                                               9.8 %   67.5 %   47.1 %           51.9 %   45.5 %
   \> 3 cm                42.6 %                                                              --       77.5 %   35.3 %           63 %     38.6 %
  NO/NI                   n = 10                                                              n = 10   n = 31   n = 37          n = 44    n = 27
  Leak location                                                                                                                           
  Intrathoracic           93.2 %                                                              64 %     92.5 %   58.6 %           25 %     66 %
  Intraabdominal          45.8 %                                                              92 %     60 %     96.6 %           92.9 %   83 %
  NO/NI                   n = 12                                                              n = 21   n = 31   n = 42          n = 43    n = 24
  Associated collection                                                                                                                   
  Yes                     11.3 %                                                               7 %     95.2 %   11.1 %           90 %     97.9 %
  No                      88.7 %                                                              93 %      4.8 %   88 n = 35.9 %    10 %      2.1 %
  NO/NI                   n = 9                                                               n = 14   n = 29                   n = 41    n = 24
  Previous surgery                                                                                                                        
  Bariatric               78.6 %                                                              87.8 %   81.6 %   96.6 %          100 %     95.5 %
  Oncologic               75 %                                                                71.4 %   84.2 %   72.4 %           25.9 %   59.1 %
  NO/NI                   n = 15                                                              n = 22   n = 33   n = 42          n = 44    n = 27

EID, endoscopic internal drainage; EVT, endoscopic vacuum therapy; OTSC, over-the-scope clip; NO/NI, no experience/no information

Final percentage may be higher than 100 % as many respondents considered more than one option.

Data were collected non-anonymously and analyzed using the graphical and analytical features of www.surveymonkey.com and IBM SPSS Statistics, version 24.0 (IBM Corp., Armonk, New York, United States). Answers were described as counts and percentages for categorical variables. Continuous variables were summarized as medians and range. Regarding respondents who gave time ranges between treatment sessions, the median value of each range was used to determine the total median value.

This study was conducted according to the Declaration of Helsinki. All authors reviewed and approved the final manuscript.

Results
=======

Participants and endoscopic therapies characterization
------------------------------------------------------

A total of 163 surveys were sent and 71 (44 %) were returned. Twenty-five countries on five different continents were represented. Sixty-nine percent of the respondents (n = 49) were gastroenterologists, with the remaining 31 % (n = 22) being surgeons. Eighty-two percent of respondents (n = 58) worked in academic hospitals and 18 % (n = 13) in non-academic teaching hospitals. The number of patients with anastomotic leaks treated within each therapeutic endoscopy unit in 1 year ranged from 1 to 4 at nine centers (13 %) to \> 40 at five hospitals (7 %) ( [Fig. 2](#FI1611-2){ref-type="fig"} ). Respondents had a median of 10 years \[1 -- 36\] of experience.

![Respondents' answers to how many patients with anastomotic leaks does your therapeutic endoscopy unit usually treat in 1 year.](10-1055-a-1005-6632-i1611ei2){#FI1611-2}

Placement of self-expandable metal stents (SEMS) was the technique most available in each department (97 %), followed by OTSC (89 %) and EID (79 %) ( [Fig. 3](#FI1611-3){ref-type="fig"} ). Stent placement was the technique most frequently used (AR: 6.3), followed by EID (AR: 4.7), OTSC (AR: 4.6) and EVT (AR: 4.1) ( [Table 1](#TB1611-1){ref-type="table"} ). AR for each continent, specialty, years of experience and patients treated per year are represented in **Supplementary Table 1.**

![Respondents' answers to techniques available in endoscopic departments.](10-1055-a-1005-6632-i1611ei3){#FI1611-3}

Leaks characteristics
---------------------

Location (94 %), size (93 %), chronicity (91 %) and associated cavity (90 %) were the most relevant characteristics considered by respondents to impact choice of treatment. Sixty-five percent of the respondents treat bariatric leaks differently from oncologic surgery leaks. Collections not reachable by endoscopy (69 %) and insufficient internal drainage (66 %) were the most common indications for need for additional percutaneous/surgical drainage ( **Supplementary Table 2** ).

Self-expandable stents
----------------------

Fifty-six percent of the 69 respondents with stent experience reported fully-covered SEMS (FC-SEMS) to be their usual first option, while 42 % preferred partially-covered SEMS (PC-SEMS). The majority (80 %) used techniques to minimize stent migration, with 38 % (n = 21) of them using combined therapies; placement of PC-SEMS is usually the preferred technique (45 %), followed by suture of the stent to the mucosa (33 %) and anchoring the stent with TTS clips (25 %) or OTSC (16 %).

Additional techniques to minimize stent migration are considered in patients with previous stent migration (52 %), if incomplete sealing between stent and esophageal wall (34 %) and when stents placed across jejunal anastomoses (19 %) ( [Table 3](#TB1611-3){ref-type="table"} ).

###### Respondents' answers to opinion probing questions regarding primary closure techniques.

  Technique                                                                               Question                                     Answer                     \%
  --------------------------------------------------------------------------------------- -------------------------------------------- -------------------------- --------
  Stents [1](#FN1611-2){ref-type="table-fn"}                                              Self-expandable stent -- first option        Fully-covered              56.5 %
  Partially-covered                                                                       42 %                                                                    
  Plastic                                                                                  1.4 %                                                                  
  Techniques to minimize stent migration (in patients without previous stent migration)   TTS clips/OTSC                               36.2 %                     
  Suture                                                                                  33.3 %                                                                  
  PC-SEMS                                                                                 44.9 %                                                                  
  None                                                                                    20.3 %                                                                  
  When to use additional techniques to minimize stent migration?                          Patients with previous stent migration       52.2 %                     
  Incomplete sealing between stent and esophageal wall                                    34.3 %                                                                  
  Jejunal anastomoses                                                                     19.4 %                                                                  
  Never                                                                                   11.9 %                                                                  
  Always                                                                                  25.4 %                                                                  
  Common stent dwell time                                                                 2 weeks                                       6 %                       
  4 weeks                                                                                 49.3 %                                                                  
  6 weeks                                                                                 28.4 %                                                                  
   ≥ 8 weeks                                                                              16.4 %                                                                  
  Over-the-scope clips [2](#FN1611-3){ref-type="table-fn"}                                Time limit between leak and OTSC placement    \< 7 days (acute leaks)   65.6 %
  1 to 6 weeks (early leaks)                                                              37.5 %                                                                  
  6 to 12 weeks (late leaks)                                                               6.3 %                                                                  
   \> 12 weeks (chronic leaks)                                                             9.4 %                                                                  
  Not relevant                                                                            20.3 %                                                                  
  Epithelial ablation prior to OTSC placement                                             Always                                       17 %                       
   \> 90 % of the cases                                                                   20.8 %                                                                  
  75 % to 90 % of the cases                                                               13.2 %                                                                  
  50 % to 75 % of the cases                                                               11.3 %                                                                  
   \< 50 % of the cases                                                                   20.8 %                                                                  
  Never                                                                                   17 %                                                                    
  Endoscopic suture [3](#FN1611-4){ref-type="table-fn"}                                   Epithelial ablation prior to suture          Always                     36.1 %
   \> 90 % of the cases                                                                   16.7 %                                                                  
  75 % to 90 % of the cases                                                                5.6 %                                                                  
  50 % to 75 % of the cases                                                                2.8 %                                                                  
   \< 50 % of the cases                                                                   25 %                                                                    
  Never                                                                                   13.9 %                                                                  

OTSC, over-the-scope clip; PC-SEMS,partially covered self-expandable metal stent; TTS, through-the-scope

Two to four endoscopists reported no experience with stents placement.

Seven to 18 respondents reported no experience with OTSC placement.

Thirty-five respondents reported no experience with endoscopic suture.

The most common stent dwell time reported was 4 weeks (49 %) (range: 2 -- 10 weeks) ( [Table 3](#TB1611-3){ref-type="table"} ).

Patients with acute leaks (94 %), without associated collections (89 %), with intra-thoracic location (93 %) and less than 3 cm in diameter were considered ideal for stent placement; the majority of respondents considered both previous surgeries (bariatric or oncologic) suitable for stent placement ( [Table 2](#TB1611-2){ref-type="table"} ).

Over-the-scope clips
--------------------

Sixty-six percent and 37 % of the 64 participants with OTSC experience reported placing them in acute and early leaks, respectively; 17 % reported always performing epithelial ablation/damage prior to OTSC application, with 62 % performing it at least in half of procedures ( [Table 3](#TB1611-3){ref-type="table"} ).

Patients without associated collections (93 %), with intra-abdominal location (92 %), up to 1 cm in diameter (77 %) and resulting from previous bariatric surgery (88 %) were considered ideal patients for OTSC placement ( [Table 2](#TB1611-2){ref-type="table"} ).

Endoscopic vacuum therapy
-------------------------

Seventy-five percent of the 40 respondents with EVT experience reported changing the polyurethane sponge every 3 to 5 days; 72 % applied similar negative pressure for intra-thoracic and intra-abdominal leaks. Most commonly, negative pressures from 70 to 100 mm Hg (41 %) and 100 to 125 mm Hg (\~35 %) were used (  [Table 4](#TB1611-4){ref-type="table"} ).

###### Respondents' answers to opinion probing questions regarding secondary closure techniques.

  Technique                                                          Question                                                          Answer                                                        \%
  ------------------------------------------------------------------ ----------------------------------------------------------------- ------------------------------------------------------------- --------
  Endoscopic vacuum therapy [1](#FN1611-5){ref-type="table-fn"}      Approach in patients with large cavities but small leak defects   Intraluminal EVT                                              28.2 %
  Balloon dilation and intracavitary EVT                             56.4 %                                                                                                                          
  EVT plus stent                                                     15.4 %                                                                                                                          
  How often change sponge in EVT                                      \< 3 days                                                         5 %                                                          
  Every 3 to 5 days                                                  75 %                                                                                                                            
  Every 5 to 7 days                                                  15 %                                                                                                                            
  Case by case                                                        5 %                                                                                                                            
  Negative pressure for intra-thoracic/intra-abdominal leaks          \< 70 mm Hg                                                      16.2 %                                                        
  70 mm to 100 mm Hg                                                 40.5 %                                                                                                                          
  100 mm to 125 mm Hg                                                35.9 %/35.1 %                                                                                                                   
   \> 125 mm Hg                                                       7.7 %/8.1 %                                                                                                                    
  When stent-over-sponge                                             If difficulties in directing vacuum force towards the leak        36.7 %                                                        
  To seal the sponge from the gastrointestinal lumen                 36.7 %                                                                                                                          
  Never                                                              43.3 %                                                                                                                          
  Endoscopic septotomy [2](#FN1611-6){ref-type="table-fn"}           When perform additional balloon dilation                          If associated transgastric hyper-pressure (stricture/twist)   80.6 %
  Always                                                             12.9 %                                                                                                                          
  Never                                                               6.5 %                                                                                                                          
  Minimal time interval since surgery                                2 weeks                                                           15.6 %                                                        
  4 weeks                                                            56.3 %                                                                                                                          
   \> 6 weeks                                                        28.1 %                                                                                                                          
  Limits of septotomy                                                Cavity length behind septum                                       47.1 %                                                        
  Case-by-case                                                       52.9 %                                                                                                                          
  Need for further sessions                                          Yes                                                               90 %                                                          
  No                                                                 10 %                                                                                                                            
  When further situations                                            Leak clearance                                                    30 %                                                          
  Residual septum                                                    50 %                                                                                                                            
  If cavity is not healing                                            5 %                                                                                                                            
  Larger collections                                                 15 %                                                                                                                            
  Time between sessions                                              Median, range (n = 20)                                            11 days (6 -- 35)                                             
  Endoscopic internal drainage [3](#FN1611-7){ref-type="table-fn"}   When to perform necrosectomy                                      Always                                                         5.4 %
  If presence of necrosis                                            64.3 %                                                                                                                          
  Never                                                              30.4 %                                                                                                                          
  Which stents                                                       Number                                                            Single                                                        11.1 %
  Double                                                             82.2 %                                                                                                                          
  One or the other                                                    6.7 %                                                                                                                          
  Length                                                             Shorter                                                           61.9 %                                                        
  Longer                                                             33.3 %                                                                                                                          
  One or the other                                                    4.8 %                                                                                                                          
  Time between sessions                                              Median, range (n = 47)                                            14 days (1 -- 90)                                             
  Time until oral diet resumption                                    Median, range (n = 42)                                             4.5 days (0 -- 42)                                           
  End of treatment                                                   12.5 %                                                                                                                          

EVT, endoscopic vacuum therapy

Thirty-one to 41 endoscopists reported no experience with EVT.

Seven to 41 endoscopists reported no experience with endoscopic septotomy.

Five to 29 endoscopists reported no experience with endoscopic internal drainage.

Regarding patients with large cavities but small leak defects, 56 % performed balloon dilation and intracavitary EVT, while 28 % placed the sponge intraluminally; 37 % considered stent-over-sponge if difficulties in directing the vacuum force towards the leak, while 37 % considered it to seal the sponge from the gastrointestinal lumen ( [Table 4](#TB1611-4){ref-type="table"} ).

Patients with chronic leaks (72 %), with associated collections (95 %), with intra-thoracic location (92 %) and with more than 2 cm in diameter were considered ideal for EVT therapy; the majority of respondents considered both previous surgeries suitable for EVT ( [Table 2](#TB1611-2){ref-type="table"} ).

Endoscopic suture
-----------------

Thirty-six percent of 36 respondents with suturing experience reported always performing epithelial ablation/damage prior to suturing, while 61 % performed it in at least half of procedures ( [Table 3](#TB1611-3){ref-type="table"} ).

Patients with acute leaks (89 %), without associated collections (89 %), up to 2 cm in diameter, with intra-abdominal location (97 %) and resulting from previous bariatric surgery (97 %) were considered ideal for endoscopic suturing ( [Table 2](#TB1611-2){ref-type="table"} ).

Endoscopic septotomy
--------------------

Fifty-six percent of the 32 respondents with septotomy experience reported that the minimal time interval from surgery should be 4 weeks; 53 % considered that limits of septotomy should be defined on a case-by-case basis. Regarding patients with previous sleeve gastrectomy, 13 % always performed additional balloon dilation, while 81 % only performed it if associated transgastric hyper-pressure. Ninety percent considered the need to perform further septotomy sessions, with presence of residual septum (50 %) and incomplete drainage (30 %) being the main indications; a median of 11 days (6 -- 35) between treatments was reported ( [Table 4](#TB1611-4){ref-type="table"} ).

Patients with chronic leaks (100 %), with associated collections (90 %), with intra-abdominal location (93 %) and resulting from previous bariatric surgery (100 %) were considered the ideal patients for endoscopic septotomy; all leak sizes were considered amenable to endoscopic septotomy ( [Table 2](#TB1611-2){ref-type="table"} ).

Endoscopic internal drainage
----------------------------

The majority of respondents with EID experience reported preferring placement of two plastic stents (82 % of 45) and shorter stents (62 % of 21) for drainage; 30 % of 56 respondents referred to never performing necrosectomy. A median of 14 days (1 -- 90) between stents exchange was reported. A median of 4.5 days (0 -- 42) until oral diet resumption was reported, with 21 % of respondents (n = 9) starting the day of procedure or day after ( [Table 4](#TB1611-4){ref-type="table"} ).

Patients with chronic leaks (65 %), with associated collections (97 %), with intra-abdominal location (83 %), up to 2 cm in diameter and resulting from previous bariatric surgery (95%) were considered ideal for endoscopic internal drainage ( [Table 2](#TB1611-2){ref-type="table"} ).

Endoscopic failure
------------------

Persistent inflammation with clinical sepsis (55 %) was the definition most commonly reported for endoscopic failure, followed by inability to resume oral feeding (42 %), duration of treatment (39 %), chronic reepithelized fistula (37 %), number of endoscopic sessions (30 %) and closure not achieved after 1 month of treatment with one single technique (28 %).

Clinical cases
--------------

EVT was the therapeutic option most often chosen (27 %) in post Ivor-Lewis esophagectomy with an intra-thoracic associated collection (clinical case 1), followed by stent placement plus drainage (23 %) and stent placement (14 %) ( [Fig. 4a](#FI1611-4){ref-type="fig"} ); EVT and EID were the therapeutic options most often chosen in post-sleeve gastrectomy 2 cm in diameter (clinical case 2) and post RYGB with an intraabdominal associated collection (clinical case 3) (21 % and 20 %, respectively), followed by stent placement plus drainage (17 % and 14 %) ( [Fig. 4b](#FI1611-4){ref-type="fig"} , [Fig. 4c](#FI1611-4){ref-type="fig"} ); surgery was the therapeutic option most often chosen in post total gastrectomy (clinical case 4) (24 %), followed by stent placement with or without drainage (19 %) ( [Fig. 4d](#FI1611-4){ref-type="fig"} ).

![Respondents' answers to clinical cases section.](10-1055-a-1005-6632-i1611ei4){#FI1611-4}

Discussion
==========

Therapeutic endoscopy plays a major role in management of UGI anastomotic leaks, offering an effective treatment alternative to repeat surgery [@JR1611-10] . The available endoscopic approaches range from primary to secondary closure techniques, with varying degrees of technical and clinical success and adverse events, generating a lack of consensus regarding the most appropriate endoscopic management [@JR1611-11] .

This survey shows that placement of stents, specifically SEMS, is the technique most available and most frequently used in almost every department. Even though OTSC are also well-represented, they are not a common first option, as represented in the clinical cases section. This is probably related to the need for pliable tissue for successful placement, as well as risk of leak recurrence due to OTSC displacement [@JR1611-8] [@JR1611-12] . Other reasons for failed closure may be related to poor integrity of the tissue surrounding the leak as a result of ischemia and inflammation as well as poor/partial placement over often large defects. On the other hand, EID and EVT seem to be increasingly used techniques; this is probably related to the fact that closing leaks with tissue apposition techniques or diversion therapy does not seem to be the ideal treatment strategy in some cases, especially in late or chronic leaks. EVT and EID allow optimal drainage of the cavity, ensuring granulation, utilizing the concept of keeping the leak open [@JR1611-12] .

The majority of participants considered that bariatric leaks should be treated differently from oncologic leaks, with location, size, chronicity, and associated cavity being the most relevant leak characteristics. Need for additional percutaneous/surgical drainage is almost always considered when closure techniques (tissue apposition or diversion techniques) are chosen, as internal drainage is not achieved, either by the collection not being reachable (69 %) or sealed (66 %). All of these is reflected in clinical cases choices. EVT and stent placement, with or without percutaneous/surgical drainage, were the therapeutic options most often chosen in patients with previous oncologic surgery, while EVT and EID were the therapeutic options most often chosen in patients with previous bariatric surgery. Interestingly, surgery was the first option in post-total gastrectomy case (24 % of respondents), despite no previous endoscopic treatment failure nor presence of uncontained leak. This might be explained by the almost complete leak of the anastomosis.

Regarding self-expandable stents, both FC (56 %) and PC-SEMS (42 %) were similarly selected as first options, even in patients without previous stent migration; besides PC-SEMS, 35 % of respondents used other additional techniques to minimize stent migration (in patients without previous stent migration), with endoscopic suturing of FC-SEMS being the preferred technique, as it seems to lower rates of stent migration [@JR1611-13] . Optimal duration of stent dwell is unknown and is likely related to leak classification and size as well as patient-related factors [@JR1611-14] . Stent dwell time ranged from 4 to 6 weeks in 77 % of respondents.

Regarding endoscopic suturing, respondents believed it provides the ability to close larger defects than OSTC (2 cm versus 1 cm). Both require robust mucosa to hold the sutures when tissue is pulled in apposition [@JR1611-8] ; epithelial ablation/damage to the defect edges before OTSC or suturing may increase procedure success and result in a more durable seal, with \~60 % of respondents performing it in more than half of procedures.

Regarding EVT, sponges can be placed intracavitary and/or intraluminal, depending on the defect size and presence of an extraluminal cavity [@JR1611-1] . Even though intraluminal EVT might be easier and safer than intracavitary EVT [@JR1611-12] , the majority (56 %) of respondents preferred to perform balloon dilation and intracavitary EVT, as leak closure might be better [@JR1611-12] . One of the great disadvantages of EVT is the need for repeat endoscopic procedures, as the majority of respondents (90 %) changed the polyurethane sponge every 3 to 5 days or 5 to 7 days.

Similar to peripancreatic collections drainage, an organized walled-off collection must be established for endoscopic septotomy to be safe and effective. This was reflected by the majority of respondents (56 %), who only consider it at least 4 weeks after surgery. Management of the downstream stenosis within the sleeve that creates an unfavorable pressure gradient was also considered critical to enhance drainage and correction of one of the underlying physiologic defects that predisposed and perpetuated the leak. Need for repeated septotomy (90 %) was mostly based on presence of residual septum (50 %) or incomplete clearance of the cavity (30 %).

Although EID with transgastric stents appears to be effective, controversies exist regarding optimal technique [@JR1611-15] . Even though necrosectomy may expedite clinical improvement, 30 % of respondents reported never doing it. A median of 4.5 days until oral diet resumption was reported, with 21 % starting it the day of or after procedure, as it is believed oral contents do not enter the perigastric cavity. Regarding stent exchange, while some saw no value in routine stent exchange unless necrosectomy was also performed [@JR1611-15] , performance of multiple procedures may allow to evaluate treatment progression to adapt internal drainage, as well as promote healing by inducing trauma in the pseudocavity with exchange of the pigtail stents [@JR1611-16] .

As there are no comparative studies between the different endoscopic techniques, it is difficult to establish a therapeutic algorithm in these patients. Determining optimal therapy for such patients requires careful examination of patient clinical status, anastomotic defect, and a review of all available options, local expertise, and previous experience. The approach to UGI anastomotic leaks should always be individualized and multidisciplinary. Considering the majority of respondents' answers, acute and small leaks without associated collections may be considered for stent placement (up to 3 cm), OSTC placement (up to 1 cm) or endoscopic suture (up to 2 cm). In the setting of associated collection, these techniques can still be considered if external drainage is also performed; if not, EVT, EID and endoscopic septotomy should be considered, with EVT and EID being an option in acute and chronic leaks, while endoscopic septotomy should only be performed in leaks with more than 4 weeks' duration. While endoscopic septotomy can be considered for all leak sizes, EID is ideal for leaks up to 2 cm and EVT for leaks larger than 2 cm. Intrathoracic leaks may be better served with stents or EVT, and intraabdominal leaks with OTSC, suturing, septotomy or EID. Leaks resulting from previous bariatric surgery should ideally be treated with OTSC, suture, septotomy or EID, while stents and EVT can be considered for leaks related to bariatric and oncologic surgeries.

Conclusion
==========

In conclusion, this study provides an overview of the techniques used for endoscopic management of UGI leaks and shows that there is wide variation in management of patients with UGI anastomotic leaks, even among the most expert in the field, particularly concerning difficult-to-treat patients, possibly reflecting the poor quality of evidence available at the moment. Limitations of our study include a survey response rate of only 44 % which may subject the study to bias, making interpretation of results more challenging. However, this study presents information which to date has not been available, with inclusion of experts from various countries, different opinion questions regarding each technique, and different clinical scenarios. Even though there is no consensus on the definition of endoscopic failure, persistent inflammation with clinical sepsis and impossibility to resume oral feeding should be strongly considered. Future prospective studies should address these issues, and for which transnational collaborations are urgently needed, so that we move from an expert- to an evidence- and personalization-based care in endoscopic treatment of upper anastomotic leaks.
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